In the Sensei’s Corner this week, we welcome LaToya Shamboo, CEO and Founder of Black Girl Digital, a premium black female marketing and influencers agency where we explain how some changes in the regulation of data privacy is affecting social and influencer marketing.
This week, we discuss the following article:
Additional Resources discussed:
- Starting the Decade by Giving You More Control Over Your Privacy
- Building a more private web: A path towards making third party cookies obsolete
- Guiding You Through Your Privacy Choices
- Now You Can See and Control the Data That Apps and Websites Share With Facebook
LISTEN, LIKE, SUBSCRIBE, COMMENT, SHARE!
Article #1: Starting the Decade by Giving You More Control Over Your Privacy By Mark Zuckerberg, Founder and Chief Executive Officer
2020 already started with a bang when Google Chrome announced the end of what programmatic ninjas know as 3rd party cookies. Google is truly trying to bridge ad personalization and consumer privacy. The company said in its blog post: “new approaches to ensure that ads continue to be relevant for users,” while minimizing “data shared with websites and advertisers.”
Another Wall garden that is nothing short of going through privacy challenges especially legally, is Facebook. Consumers can check who can see their post and other profile info via a Privacy Check up. We can now check Off-Facebook Activity which is Facebook’s way of showing the consumer data collected by other companies/businesses and how they use that to show you relevant ads.
Article #2: FDA to Study Perceptions of Instagram Influencers and Their Disclosures By Zachary Brennan
US Food and Drug Administration’s (FDA) Office of Prescription Drug Promotion (OPDP) announced recently that it’s working on two studies, one of which will focus on Instagram influencers and how people perceive what they say.
More specifically, the research is to understand how payment disclosure influences consumers decisions or reactions. They mentioned how back in 2015 Kim K received a warning letter from the FDA without disclosing it was a paid advertisement when promoting a morning sickness drug.
Diversity & Inclusion segment:
LaToya’s Book of the Moment: